SCHEMBL4263241

SCHEMBL4263241

Cc1noc(-c2ccccc2)c1CCN=C=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.40
HDAC1 Q13547 2/20 0.39
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BRD4 O60885 2/20 0.37
BRD2 P25440 1/20 0.37
PTGS1 P23219 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TDO2 P48775 1/20 0.36
LPAR1 Q92633 1/20 0.35
LPAR3 Q9UBY5 1/20 0.35
AOC3 Q16853 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
TRPA1 O75762 1/20 0.34
PTPN1 P18031 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11994167 0.76 BRD4 (0.43) SLC6A9HDAC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL27743828 0.76 BRD4 (0.43) SLC6A9HDAC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL3984438 0.76 BRD4 (0.45) SLC6A9HDAC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL5773143 0.75 FFAR4 (0.51) SLC6A9HDAC1ALDH1A1MAPTPTGS1
SCHEMBL8976521 0.75 BRD4 (0.48) SLC6A9ALDH1A1MAPTSMN1; SMN2BRD4
SCHEMBL11897018 0.75 SMN1; SMN2 (0.49) SLC6A9HDAC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL5776962 0.74 NR4A2 (0.51) SLC6A9HDAC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL2407274 0.73 BRD4 (0.43) HDAC1ALDH1A1MAPTSMN1; SMN2BRD4
SCHEMBL13828379 0.72 L3MBTL1 (0.48) HDAC1ALDH1A1MAPTSMN1; SMN2BRD4
SCHEMBL2413945 0.72 BRD4 (0.46) SLC6A9HDAC1ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059502-A2 PROLINE UREA CCR1 ANTAGONISTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR INFLAMMATION LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-05-20 EP disclosed
WO-2008011392-A2 PROLINE UREA CCR1 ANTAGONISTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR INFLAMMATION LIGAND PHARMACUETICALS INCORPORATED (US) 2008-01-24 WO disclosed